Disc Medicine Inc. Announces Webinar to Highlight Strategic Direction in Hematologic Disease Treatment
Disc Medicine, Inc. is a clinical-stage biopharmaceutical company focused on developing novel treatments for serious hematologic diseases, with a market capitalization of approximately $1.72 billion USD.
2 minutes to read